Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1982
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Comutagenic Effect Of Norharman With Aminopyridine Derivatives
Author:
Wakabayashi, K., Yahagi, T., Nagao, M. and Sugimura, T.
Year:
1982
Bibliographic source:
MUTAT. RES. 105:205-210,1982

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
The purpose of the study was to determine the comutagenic effect of norharman with 2-amino-4-methylpyridine with or without metabolic activation in Salmonella typhimurium strains TA98 and TA100.
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
4-methyl-2-pyridylamine
EC Number:
211-780-9
EC Name:
4-methyl-2-pyridylamine
Cas Number:
695-34-1
Molecular formula:
C6H8N2
IUPAC Name:
4-methylpyridin-2-amine
Constituent 2
Reference substance name:
2-Amino-4-methylpyridine
IUPAC Name:
2-Amino-4-methylpyridine
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
No specific details on test material used for the study.

Method

Target gene:
His-gene
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 98
Details on mammalian cell type (if applicable):
No other details were provided in the study report.
Additional strain / cell type characteristics:
not specified
Species / strain / cell type:
S. typhimurium TA 100
Details on mammalian cell type (if applicable):
No other details were provided in the study report.
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
Kanechlor 500-induced rat liver S9.
Test concentrations with justification for top dose:
Up to 2 mg/plate.
Vehicle / solvent:
- Vehicle used: DMSO
Controls
Negative solvent / vehicle controls:
not specified
Positive controls:
not specified
Remarks:
No information on controls were provided in the study report
Details on test system and experimental conditions:
METHOD OF APPLICATION: preincubation

DURATION
- Preincubation period: 20 min at 37°C
- Incubation period: 2 days

NUMBER OF REPLICATIONS: Not provided.

NUMBER OF CELLS EVALUATED: Not provided.

DETERMINATION OF CYTOTOXICITY: No data
Evaluation criteria:
No information is available in the study report.
Statistics:
No data

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
not specified
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
not specified
Positive controls validity:
not specified
Additional information on results:
No additional details were provided in the study report.

Applicant's summary and conclusion

Conclusions:
2-Amino-4-methylpyridine was non-mutagenic in the Ames test when tested up to 2 mg/plate with and without metabolic activation in Salmonella strains TA98 and TA 100 in the presence of norharman.
Executive summary:

2-Amino-4-methylpyridine was non-mutagenic in the Ames test when tested up to 2 mg/plate with and without metabolic activation in Salmonella strains TA98 and TA 100 in the presence of norharman.